In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

(2009) Pierre Farmer et al.   NATURE MEDICINE

Estrogen andMYBin breast cancer: potential for new therapies

(2008) Thomas J Gonda et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Inconsistent Criteria Used in American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

(2008) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c

(2008) Marianne Kyndi et al.   RADIOTHERAPY AND ONCOLOGY

ArylamineN-acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor-positive tumors

(2007) Larissa Wakefield et al.   GENES CHROMOSOMES & CANCER